A
Angelo Luis Caron
Researcher at University of São Paulo
Publications - 8
Citations - 189
Angelo Luis Caron is an academic researcher from University of São Paulo. The author has contributed to research in topics: Skin cancer & Transduction (genetics). The author has an hindex of 6, co-authored 8 publications receiving 80 citations.
Papers
More filters
Journal ArticleDOI
Nanotechnology approaches in the current therapy of skin cancer.
Lívia Neves Borgheti-Cardoso,Juliana Santos Rosa Viegas,Ana Vitoria Pupo Silvestrini,Angelo Luis Caron,Fabíola Silva Garcia Praça,Marcelo Kravicz,Maria Vitória Lopes Badra Bentley +6 more
TL;DR: In this review, nanotechnological tools for skin cancer will be summarized and discussed, and the use of NPs to deliver chemotherapeutics, immune and vaccine molecules and nucleic acids will be reviewed and discussed.
Journal ArticleDOI
Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis.
Juliana Santos Rosa Viegas,Fabíola Silva Garcia Praça,Angelo Luis Caron,Isabella Suzuki,Ana Vitoria Pupo Silvestrini,Wanessa Silva Garcia Medina,José Orestes Del Ciampo,Marcelo Kravicz,Maria Vitória Lopes Badra Bentley +8 more
TL;DR: The developed system was successfully to treat in vivo psoriatic animal model induced by imiquimod and the synergic combination was reported here for the first time, exhibiting a synergic effect between the TAC and TNF-α siRNA.
Journal ArticleDOI
Advances in lyotropic liquid crystal systems for skin drug delivery.
Ana Vitoria Pupo Silvestrini,Angelo Luis Caron,Juliana Santos Rosa Viegas,Fabíola Silva Garcia Praça,Maria Vitória Lopes Badra Bentley +4 more
TL;DR: Why these systems proved to be a platform for the design of nanocarrier drug delivery, with an emphasis on topical and transdermal applications, and the results of several studies support the innovations in this field are predicted.
Journal ArticleDOI
Current Non-viral siRNA Delivery Systems as a Promising Treatment of Skin Diseases.
Juliana dos Santos Rosa,Isabella Suzuki,Marcelo Kravicz,Angelo Luis Caron,Ana Vitória Pupo,Fabíola Silva Garcia Praça,Maria Vitória Lopes Badra Bentley +6 more
TL;DR: The treatment of skin diseases based on topical delivery of siRNA, which act by inhibiting the expression of target transcripts, offers many potential therapeutic advantages for suppressing genes into the skin.
Book ChapterDOI
Platforms for Recombinant Therapeutic Glycoprotein Production.
TL;DR: This chapter covers the general aspects of therapeutic recombinant glycoproteins and the platforms that are being employed for their production.